KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Free Cash Flow: 2010-2025

Historic Free Cash Flow for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to -$37.8 million.

  • Opko Health's Free Cash Flow rose 55.56% to -$37.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$212.1 million, marking a year-over-year decrease of 6.03%. This contributed to the annual value of -$208.5 million for FY2024, which is 368.83% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Free Cash Flow is -$37.8 million, which was up 56.42% from -$86.7 million recorded in Q2 2025.
  • Opko Health's 5-year Free Cash Flow high stood at $28.9 million for Q3 2023, and its period low was -$86.7 million during Q2 2025.
  • For the 3-year period, Opko Health's Free Cash Flow averaged around -$37.7 million, with its median value being -$37.8 million (2025).
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 172.54% in 2023, then plummeted by 427.63% in 2024.
  • Quarterly analysis of 5 years shows Opko Health's Free Cash Flow stood at -$12.4 million in 2021, then crashed by 206.76% to -$38.0 million in 2022, then dropped by 8.85% to -$41.3 million in 2023, then dropped by 20.59% to -$49.8 million in 2024, then spiked by 55.56% to -$37.8 million in 2025.
  • Its Free Cash Flow stands at -$37.8 million for Q3 2025, versus -$86.7 million for Q2 2025 and -$37.7 million for Q1 2025.